In the middle of yet another year, week, day when it seems as if nothing is working, the chocolate trade is rewarding investors in a desperate search for some edible alpha.
The stock dropped after the Treasury Secretary nominee admitted he used the software to do his taxes.
While Obama takes the oath, all eyes in the markets will be on the financial sector following RBS's monster loss announcement in the UK.
Biotechnology stocks are getting a lot of chatter already in this very young year.
Are the technical forces powerful enough to keep the S&P 500 on its current uptrend toward 1,000? Also why isn't Apple CEO Steve Jobs making the keynote address at Macworld?
This last gasp by the market is now in the hands of Goldman Sachs. The recently-converted commercial bank posts fiscal 4th quarter results Tuesday morning.
Seems like more investors are buying on bad news. Find out why the traders believe this is a "somewhat encouraging" sign!
Despite weakness Monday, the vital signs of the recent rebound are quite impressive. And a few playable trends may have made themselves known...
Jim Cramer is disgusted with the tactics taken by this hedge fund activist.
According to Carter Worth of Sterne Agee, shares of Boeing have some serious tailwinds behind them.
Will Black Friday even make a dent at the mall this year? Jim Cramer has a stock up his sleeve that could run ahead of the rest of them.
Headlines after the bell Monday: Amgen, Palo Alto Networks, Workday & more
Get the best of CNBC in your inbox